<生产厂家价格>

肾上腺髓质素(22-52 ),人

肾上腺髓质素(22-52 ),人用途

Adrenomedullin (AM) (22-52), human 为肾上腺髓质素 (adrenomedullin receptor) 受体拮抗剂,同时在猫后肢血管床中,对降钙素基因相关肽 (CGRP) 受体也具有拮抗作用。

肾上腺髓质素(22-52 ),人名称

[ CAS 号 ]:
159899-65-7

[ 中文名 ]:
肾上腺髓质素(22-52 )(人体)

[ 英文名 ]:
Adrenomedullin (22-52) (human)

[英文别名 ]:

MFCD00282038
Adrenomedullin (AM) (22-52), human

肾上腺髓质素(22-52 ),人生物活性

[ 描述 ]:

Adrenomedullin (AM) (22-52), human 为肾上腺髓质素 (adrenomedullin receptor) 受体拮抗剂,同时在猫后肢血管床中,对降钙素基因相关肽 (CGRP) 受体也具有拮抗作用。

[ 相关类别 ]:

信号通路 >> G 蛋白偶联受体/G 蛋白 >> CGRP受体

信号通路 >> 神经信号通路 >> CGRP受体

多肽产品

研究领域 >> 心血管疾病

[ 靶点 ]

Adrenomedullin receptor, CGRP receptor[1]

[体外研究]

肾上腺髓质素(AM)(22-52),人类对120nmol的肾上腺髓质素(ADM)的后肢灌注压反应没有影响。然而,肾上腺髓质素(AM)(22-52),人类选择性地和可逆地降低血管扩张剂对人降钙素基因相关肽(hCGRP)的反应在30nmol,具有与CGRP拮抗剂类似的作用[1]。

[参考文献]

[1]. Champion HC, et al. Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat. Am J Physiol. 1997 Jan;272(1 Pt 2):R234-42.

[相关活性小分子]

肾上腺髓质素(22-52 ),人物理化学性质

[ 分子式 ]:
C₁₅₉H₂₅₂N₄₆O₄₈

[ 分子量 ]:
3576.03

[ 储存条件 ]:
−20°C

肾上腺髓质素(22-52 ),人安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

肾上腺髓质素(22-52 ),人文献

Adrenomedullin receptor binding sites in rat brain and peripheral tissues.

Eur. J. Pharmacol. 474 , 165-174, (2003)

The existence of specific adrenomedullin receptor binding sites was investigated using the agonist peptide fragment [125I]human adrenomedullin-(13-52) in rat brain, lung and vas deferens homogenates. ...

Adrenomedullin is anti-apoptotic in osteoblasts through CGRP1 receptors and MEK-ERK pathway.

J. Cell Physiol. 215 , 122-128, (2008)

Adrenomedullin (ADM) has been shown to mediate multifunctional responses in cell culture and animal system such as regulation of growth and apoptosis. ADM stimulates the proliferation of osteoblasts i...

Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis.

Oncogene 22 , 1238-1242, (2003)

Since it is reported that adrenomedullin (AM) upregulated by hypoxia inhibits hypoxic cell death, we examined the effects of AM antagonist (AM C-terminal fragment; AM(22-52)) on the growth of pancreat...

更多文献